These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6209204)

  • 21. Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells.
    Issekutz T; Chu E; Geha RS
    J Immunol; 1982 Oct; 129(4):1446-50. PubMed ID: 6286767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloned murine Ia+ BK-BI-2.6.C6 T cells function as accessory cells presenting protein antigens to long-term-cultured antigen-specific T cell lines.
    Reske-Kunz AB; Reske K; Rüde E
    J Immunol; 1986 Mar; 136(6):2033-40. PubMed ID: 3512709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of in vitro immune responses in humans using T cell clones and monoclonal antibodies].
    Ogasawara K
    Hokkaido Igaku Zasshi; 1984 May; 59(3):346-55. PubMed ID: 6207087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen presentation by Hodgkin's disease cells.
    Fisher RI; Cossman J; Diehl V; Volkman DJ
    J Immunol; 1985 Nov; 135(5):3568-71. PubMed ID: 3876389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles-specific T cell clones derived from a twin with multiple sclerosis: genetic restriction studies.
    Richert JR; McFarland HF; McFarlin DE; Johnson AH; Woody JN; Hartzman RJ
    J Immunol; 1985 Mar; 134(3):1561-6. PubMed ID: 2578511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of class II HLA molecules in T cell activation by antigen. Implications for the autologous mixed lymphocyte reaction.
    Thorsby E; Berle E; Scott H; Braathen LR
    Behring Inst Mitt; 1983 May; (72):129-34. PubMed ID: 6100471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines.
    Reitnauer PJ; Brown LR; Hank JA; Sondel PM
    Cell Immunol; 1986 Apr; 99(1):196-208. PubMed ID: 3019572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Falcone G
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential antigen-presenting cell requirements of hapten-specific T cell lines restricted to class II determinants.
    Hanke JH; Cook RG; Lopez LA; Rich RR
    J Immunol; 1987 Apr; 138(8):2384-91. PubMed ID: 3494064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones.
    Lamb JR; Eckels DD; Lake P; Johnson AH; Hartzman RJ; Woody JN
    J Immunol; 1982 Jan; 128(1):233-8. PubMed ID: 6172480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
    Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
    J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis.
    Sinigaglia F; Scheidegger D; Garotta G; Scheper R; Pletscher M; Lanzavecchia A
    J Immunol; 1985 Dec; 135(6):3929-32. PubMed ID: 2415590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
    Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ
    J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
    van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
    AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth of antigen specific, HLA restricted T lymphocyte clones from cerebrospinal fluid.
    Fleischer B; Bogdahn U
    Clin Exp Immunol; 1983 Apr; 52(1):38-44. PubMed ID: 6190597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.
    Peiper M; Goedegebuure PS; Alldinger I; Knoefel WT; Izbicki JR; Eberlein TJ
    Anticancer Res; 2002; 22(6A):3357-63. PubMed ID: 12530087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.